PMCB (PharmaCyte Biotech) Degree of Operating Leverage : 0.00 (As of Jan. 2025)

PharmaCyte Biotech Degree of Operating Leverage Chart

PharmaCyte Biotech Annual Data
	Trend	Apr15	Apr16	Apr17	Apr18	Apr19	Apr20	Apr21	Apr22	Apr23	Apr24
Degree of Operating Leverage		Get a 7-Day Free Trial					-	-	-	-	-

PharmaCyte Biotech Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Degree of Operating Leverage	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of PharmaCyte Biotech's Degree of Operating Leverage

For the Biotechnology subindustry, PharmaCyte Biotech's Degree of Operating Leverage, along with its competitors' market caps and Degree of Operating Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaCyte Biotech's Degree of Operating Leverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaCyte Biotech's Degree of Operating Leverage distribution charts can be found below:

* The bar in red indicates where PharmaCyte Biotech's Degree of Operating Leverage falls into.

PharmaCyte Biotech Degree of Operating Leverage Calculation

PharmaCyte Biotech's Degree of Operating Leverage for the quarter that ended in Jan. 2025 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EBIT and Revenue was used to calculate Degree of Operating Leverage.
*** Please be aware that the Degree of Operating Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

PharmaCyte Biotech  (NAS:PMCB) Degree of Operating Leverage Explanation

Degree of Operating Leverage (DOL) is a leverage ratio that measures the sensitivity of a company’s operting income, also referred to as Earnings Before Interest and Taxes (EBIT), to fluctuations in its Revenue. DOL is a method used to quantify a company’s operating risk. This risk is related to the company's structure of variable costs and fixed costs. Since the fixed costs do not allow the company to adjust the operating costs, the operating risk rises with a higher fixed-to-variable costs proportion.

A high Degree of Operating Leverage indicates that the company’s fixed costs exceed its variable costs. By increasing the sales, the company can earn more profits. In addition, the company must be able to maintain relatively high sales to cover all fixed costs.

Be Aware

The use of operating leverage varies across different industries and business sectors, and the application of Degree of Operating Leverage (DOL) should be adjusted accordingly.

PharmaCyte Biotech Degree of Operating Leverage Related Terms

Thank you for viewing the detailed overview of PharmaCyte Biotech's Degree of Operating Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaCyte Biotech Business Description